In contrast, the inhibition of the NLRP3 inflammasome via the administration of YVAD attenuated the increase in the p-FAK-to-FAK ratio in bleomycin-induced pulmonary fibrosis (Figure 4). The gene discussed is PTK2; the disease is pulmonary fibrosis.